Attralus’ Pan-Amyloid Removal Therapeutics: A New Possibility for Systemic Amyloidosis
Jonathan Wall, Co-Founder and Interim Chief Scientific Officer at Attralus discusses the latest developments in systemic amyloidosis research, stemming ...
5261 articles
Jonathan Wall, Co-Founder and Interim Chief Scientific Officer at Attralus discusses the latest developments in systemic amyloidosis research, stemming ...
Nima Farzan, CEO of Kinnate Biopharma Inc., a precision oncology company, discusses the company's investigational targeted cancer therapies which are de...
Lauren Powell, M.P.A., Ph.D., Vice President, US Health Equity & Community Wellness at Takeda, a global, values-based, R&D-driven biopharmaceutical lead...
Amanda Dilger, MD, ENT surgeon at Mass Eye and Ear discusses climate change and otolaryngology with a focus on climate health, sustainability in healthc...
Mark Varvares, MD, FACS, Chief of Otolaryngology/Head and Neck Surgery at Mass Eye and Ear talks about his study on Head and Neck Surgeon Perception of ...
Dr. Jonathan Sadeh, MD, MSc, Senior Vice President of Immunology and Fibrosis Development, Global Drug Development at Bristol Myers Squibb discusses the
Beverly Taylor, Head of Global Influenza Scientific Policy at CSL Seqirus discusses Avian influenza and its typical spread during migratory seasons and ...
Rahul Mehan, MD, Founder of East Valley Urology Center of Arizona, discusses enlarged prostate, its symptoms, and available treatment options.
Jan Wehkamp, MD, PhD, Vice President, Gastroenterology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development, LLC di...
Demian Bellumio, Chief Operating Officer and Co-Founder at Nue Life Health, a next-gen mental wellness company that leverages the power of psychedelic d...